共 26 条
[11]
Kobayashi Y., Yamashita Y., Fujii N., Takaboshi K., Kawakami T., Kawamura M., Mizukami T., Nakano H., Inhibitors of DNA topoisomerase I and II from the Coptis Rhizomes, Planta Med., 61, pp. 414-418, (1995)
[12]
Li T.K., Bathory E., LaVoie E.J., Srinivasan A.R., Olson W.K., Sauers R.R., Liu L.F., Pilch D.S., Human topoisomerase I poisoning by protoberberines: Potential roles for both drug-DNA and drug-enzyme interactions, Biochemistry, 39, pp. 7107-7116, (2000)
[13]
Krishnan P., Bastow K.F., The 9-position in berberine analogs is an important determinant of DNA topoisomerase II inhibition, Anti-Cancer Drug Des., 15, pp. 255-264, (2000)
[14]
Li W.Y., Lu H., Xu C.X., Zhang J.B., Lu Z.H., Spectroscopic and binding properties of berberine berberine to DNA and its application to DNA detection, Spectrosc. Lett., 31, pp. 1287-1298, (1998)
[15]
Ebringer L., Interaction of drugs with extranuclear genetic elements and its consequences, Teratogen. Carcinogen. Mutagen., 10, pp. 477-501, (1990)
[16]
Foltinova P., Grones J., Euglena gracilis as an eukaryotic test organism for detecting mutagens and antimutagens, Mutation Res., 393, pp. 1-6, (1997)
[17]
Krizkova L., Lopes M.H., Polonyi J., Belicova A., Dobias J., Ebringer L., Antimutagenicity of a suberin extract from Quercus suber cork, Mutation Res., 446, pp. 225-230, (1999)
[18]
Krizkova L., Nagy M., Polonyi J., Dobias J., Belicova A., Grancai D., Krajcovic J., Phenolic acids inhibit chloroplast mutagenesis in Euglena gracilis, Mutation Res., 469, pp. 107-114, (2000)
[19]
Krizkova L., Polonyi J., Kosikova B., Dobias J., Belicova A., Krajcovic J., Ebringer L., Lignin reduces of loxacin-induced mutagenicity in Euglena assay, Anticancer Res., 20, pp. 833-836, (2000)
[20]
Kost'alova D., Uhrin D., Hrochova V., Tomko J., A new bisbenzylisoquinoline alkaloid from Mahonia aquifolium (Pursh) Nutt, Collect. Czech. Chem. Commun., 52, pp. 242-246, (1987)